key: cord-0960695-fo48wzzn
authors: Lin, Neil; Verma, Daksh; Saini, Nikhil; Arbi, Ramis; Munir, Muhammad; Jovic, Marko; Turak, Ayse
title: Antiviral nanoparticles for sanitizing surfaces: a roadmap to self-sterilizing against COVID-19
date: 2021-08-13
journal: Nano Today
DOI: 10.1016/j.nantod.2021.101267
sha: 3d5e81de775baa9688311a05dbc21a733d817ed4
doc_id: 960695
cord_uid: fo48wzzn

Nanoparticles open new opportunities in merging therapeutics and new materials, with current research efforts just beginning to scratch the surface of their diverse benefits and potential applications. One such application, the use of inorganic nanoparticles in antiseptic coatings to prevent pathogen transmission and infection, has seen promising developments. Notably, the high reactive surface area to volume ratio and unique chemical properties of metal-based nanoparticles enables their potent inactivation of viruses. Nanoparticles exert their virucidal action through mechanisms including inhibition of virus-cell receptor binding, reactive oxygen species oxidation and destructive displacement bonding with key viral structures. The prevention of viral outbreaks is one of the foremost challenges to medical science today, emphasizing the importance of research efforts to develop nanoparticles for preventative antiviral applications. In this review, the use of nanoparticles to inactivate other viruses, such as influenza, HIV-1, or norovirus, among others, will be discussed to extrapolate broad-spectrum antiviral mechanisms that could also inhibit SARS-CoV-2 pathogenesis. This review analyzes the published literature to highlight the current state of knowledge regarding the efficacy of metal-based nanoparticles and other antiviral materials for biomedical, sterile polymer, and surface coating applications. Red

Human civilization has contended with disease outbreaks throughout recorded history, from the Antonine Plague of 250 to the 1720s Bubonic Plague, and the 1920 Spanish flu that are still infamous in our collective memory. For the first time, humanity has the ability to meaningfully use nanotechnology to combat 5 a major infectious disease, namely the COVID-19 pandemic caused by SARS-CoV-2. SARS-CoV-2 has spread to millions of people worldwide through a novel mechanism of binding to ACE-2 receptors in the human body using its spike protein [1] . This structure not only identifies receptors on potential host cells but also facilitates fusion between the viral envelope and the host cell membrane, 10 allowing the viral life cycle to continue unregulated [2] .

Nanotechnology has proven valuable in both understanding and combating COVID-19 with applications including nanopore sequencing for rapid diagnosis and lipid nanoparticle carriers for delivering mRNA vaccines [3] [4] [5] [6] . Beyond conventional diagnostic techniques, nanomaterials also enable accurate biosensors 15 that can detect the presence of a virus with only a microlitre of human serum [3, [7] [8] [9] . For example, the immune colloidal gold technique, an immunoassay based on labelling an antibody with plasmonic gold nanostructures, can enable an amplified fluorescent signal once a viral antigen is captured for imaging of antibody binding [9] ; a chromic sensor with functionalized gold nanoparticles 20 showing red-blue color change if the target virus is present [8] ; or functionalized graphene electrodes accurately detecting signs of COVID-19 infection through conductance changes caused by nucleocapsid protein antigen, immunoglobulins, and C-reactive protein in human serum [7] . Such technologies provide rapid and 2 J o u r n a l P r e -p r o o f scalable point of care detection of viral infection. 25 Although e↵ective pathogen detection has been made possible by nanomaterials, there remains the significant challenge of preventing infections. Transmission through contact surfaces such as doorknobs, packaging, and handrails is responsible for many preventable and nosocomial infections that cause extensive loss of life and healthcare expenditures as a pathway by which infectious 30 pathogens spread between people [10] . Contributing to SARS-CoV-2's potent transmissibility is its ability to survive for long periods on common touch surfaces before infecting a host through hand-face contact [11] , particularly in cold environments [12] [13] [14] . Therefore, targeting the virus before infection and in the early stages of its pathogenesis through self-sterilizing surfaces is an attractive 35 strategy since essential viral components such as the spike proteins are likely to be extracellular and, therefore, relatively accessible to degradation. Though there is some evidence that this may not the most virulent pathway to infection by SARS-CoV-2 [15, 16] , disinfection is the primary method of inhibiting virulent spread against viruses with no viable vaccine. Likewise, nanoparticle-based 40 disinfection could be useful against SARS-CoV-2 in areas where vaccination rollout is challenging, or to augment vaccination e↵orts.

Given the prevalence and utility of plastic-based products in modern society, actively integrating nanostructures into polymers that self-sterilize against pathogens can provide a route to slow the transmission of viral infections. Face 45 masks are another essential tool in slowing the transmission of viruses such as SARS-CoV-2, and polyimide thin films with nanoporous membranes and carbon-based nanomaterials can act as protective barriers against viruses in personal protective equipment (PPE) and air filters [3] . The surface chemistry of a polymer nanofibre filter can be fine tuned for optimal protection against 50 a specific virus [17] . However, incorrect use and disposal of PPE may put the wearer in contact with virions trapped in the fabric, increasing their risk of infec-

Metal and metal-based nanoparticles (NPs) are at the forefront of nanomaterials research due to their high specific surface area and unique chemical properties that make them candidates for applications from disease therapeutics to antiviral surface coatings. Notably, the high surface area to volume ratio of 90 nanoparticles enables e cient antiviral activity with relatively small amounts of metal. Further, their size enables ease of integration into medicines, polymers, and various surfaces [27] . Metals including copper, silver and gold exhibit the oligodynamic e↵ect with well established biocidal characteristics that continue to persist on the nano scale [28] [29] [30] . These metals and several of their oxides 95 have been widely studied to elucidate their antiviral properties and mechanisms.

Across the literature, the primary methods observed by which metal nanoparticles inhibit viruses include: [25] [26] [27] [30] [31] [32] [33] [34] • Binding or disrupting viral surface structures (e.g. spike glycoproteins) to prevent attachment and entry into host cells. 100 • Production of metal ions and reactive oxygen species (ROS) through chemical pathways that adhere to and degrade viral components such as the glycan shield, lipid envelope, protein capsid, and nucleic acids.

• Direct interaction with viral surfaces, proteins, and genetic material through the di↵usion of nanoparticles and metal ions to damage viral integrity and 105 inhibit functions such as protein synthesis and genome replication.

• Cleavage of disulfide bonds between cysteine amino acid residues to denature and disable viral glycoproteins.

These are summarized in Figure 1 . The particular mechanisms by which specific nanoparticles act on di↵erent viruses are highly variable, dependent both 

Titanium dioxide has desirable properties, including low toxicity to humans 115 and excellent UV-activated viral inhibition [35] . Its antiseptic mechanism is primarily the photocatalytic production of reactive oxygen species (ROS) such as hydroxyl radicals (OH), neutral hydroxide ions, and superoxide (O -2 ) when exposed to oxygen, moisture, and UVA photons [24, 36, 37] . ROS with unpaired electrons are highly unstable and rapidly react with biomolecules in reactions making ROS cytotoxic to a wide variety of organisms [38] [39] [40] .

The evidence supporting TiO 2 as a active antiviral coating material has been shown by a number of groups, including against human norovirus and several 125 norovirus surrogates (bacteriophage MS2, murine norovirus (MNV), and feline calicivirus (FCV) [24] ), human influenza A (A/PR8/H1N1) [37] , and herpes simplex virus 1(HSV-1) [41] . Hajkova The reduction in viral infectivity was evaluated using a glycoprotein gC monoclonal antibody, which turns brown in the presence of intact HSV-1. As shown 135 in Figure 2 , both cell cultures infected with virus samples from blank glass whether dark or UV illuminated showed active viruses(A, B) [41] . However, the viral samples exposed to TiO 2 films under UV light were inactivated and not able to infect or replicate as evidenced by the absence of brown colouration and glycoprotein gC. The antiviral mechanism is also proposed to be the destruc- 140 tion of virions by hydroxyl radicals and superoxide anions (free OH and O -2 ) produced through TiO 2 photocatalysis [41] , similar to that observed in bacteria.

The specific antiseptic mechanisms of ROS in bacteria include peroxidation of lipid membranes, carbonylation of proteins, and degradation of genetic material [38, 39, 42] . Park et al. [24] proposed that similar mechanisms may apply to this challenge through the use of fluorinated TiO 2 which can more e ciently utilize fluorescent lighting for photocatalytic disinfection [24] . Specifically, they 160 analyzed the use of nanoparticle films of TiO 2 and F-TiO 2 in UVA-activated antiviral surface coatings against various norovirus surrogates (human norovirus, MS2, MNV, and FCV). They prepared TiO 2 films by mixing TiO 2 NPs in a suspension of polyethylene glycol before spreading the mixture on a glass plate, drying at room temperature, and finally baking at 450°C for 30 minutes to bind 165 the film. A surface-fluorinated TiO 2 sample was also prepared by soaking a TiO 2 coated plate in a 30 mM pH 3.5 sodium fluoride solution for 30 minutes. Viruses samples measuring 25 µL were deposited onto both pristine TiO 2 and F-TiO 2 surfaces and exposed to 10 µW/cm 2 fluorescent lighting. Virus inactivation was subsequently measured by plaque assay or PCR RNA copy quantification [24] . in bulk phase that can damage viruses [24] . This virucuidal action was long-lived and potent, with MS2 infectivity reduced to undetectable levels after 12 hours, under common o ce lighting [24] . The retention of antiviral properties 180 under widespread indoor lighting conditions makes F-TiO 2 nanoparticle coatings promising for sterile surface applications and the prevention of virus transmission. These studies show that the photodegradation mechanism of TiO 2 can inactivate both non-enveloped viruses such as noroviruses and enveloped viruses such as HSV-1 [24, 41] . Notably, SARS-CoV-2 is an enveloped virus like HSV-1 185 with a similar fundamental lipid bilayer exterior which may be vulnerable to TiO 2 surface coatings.

With regard to the optimal substrate for TiO 2 coatings, Jalvo et al. found that TiO 2 driven photodegradation of bacteria occurs at a 50 times higher rate in 9 J o u r n a l P r e -p r o o f porous surfaces such as glass microfibre filters, compared to smooth glass slides 190 [43] . The surface coatings employed in this study used 5 nm anatase TiO 2 NPs synthesized by sol-gel with 11.5 mL of titanium tetraisopropoxide stirred with an acidic aqueous solution with a 140:1 water to nitric acid proportion that was aged and dialyzed. The nanoparticle suspension was spread over the glass slides and enriched into the glass filters by impregnation. Notably, the total 195 amount of TiO 2 required to coat the porous filters was much lower per unit area while achieving a superior overall dispersion as the glass fibres created a structure of TiO 2 microsized sheets. The nanoparticle-based TiO 2 coatings were analyzed using the methylene blue 365 nm UV-A photodegradation test against strains of Staphylococcus aureus and Pseudomonas putida. shown in other studies, ROS generation is applicable to viral inactivation as well [24, 41] . The result from this study suggests that porous surfaces may increase 205 photoactive surface area, enabling more e cient TiO 2 photocatalysis with less material and UV irradiation. NPs with an average diameter of 8 nm using a sonochemical method developed 210 by Srivastava et al. [44] and evaluated the NPs inhibitory e cacy against Newcastle disease virus (NDV), one of the most virulent poultry viruses [45] . When NDV inoculated chicken embryos were treated with varying concentrations of TiO 2 NPs, no hemagglutination was observed in NP concentrations from 6.25 µg/ml -100 µg/ml, indicating complete viral inactivation after 96 hours. The 215 suggested mechanism of action is direct NP-virus interactions that damage the viral envelope's lipids and deform the glycoprotein spikes, making the virus unable to attach and initiate infection [45] . This secondary mechanism is also supported by Mazurkova et al., who demonstrated in their study that TiO 2 NPs still exhibited antiviral activity against influenza even when not UV illuminated.

Based on their observations, it is suggested that TiO 2 NPs can also achieve viral inactivation by penetrating and disintegrating the viral envelope [46] .

Applicability to SARS-CoV-2:. The photodegradation mechanism of TiO 2 in the presence of UV wavelengths and moisture is suited to inactivating SARS-CoV-2 given that the virus spreads as aerosolized aqueous droplets that settle on 225 surfaces [11] . A TiO 2 nanoparticle-based surface coating could use the moisture in the droplets as a reagent to start the production of ROS through photocatalysis reactions, even under standard indoor lighting. Given that SARS-CoV-2 is an enveloped virus, with a lipid bilayer exterior and surface glycoproteins (see Figure ? ?), the interactions with nanoparticles and their produced ROS with 230 the SARS-CoV-2 viral membranes may compromise surface proteins such as the spike glycoprotein, which are rooted in and depend on an intact membrane for fusion with host cells [47] .

SARS-CoV-2 inhibition would then be achieved through the oxidative damage to its base proteins, lipids, and nucleic acids by reactive free radicals. Fur- atitis rat model [49] . Notably, they found that cation reactions with hydrogen peroxide can readily generate hydroxyl radicals that degrade N-linked glycosidic linkages between oligosaccharides and proteins. This interaction reduces 240 the glycosylation of glycoproteins and alters biological function. In SARS-CoV-2, the spike protein uses extensive glycosylation acquired from the human cell that produced it to shield vulnerable epitopes from immune antibodies [50] (see Figure 4 ). This glycan shield plays a crucial role in SARS-CoV-2 infectivity and helps 245 facilitate immune evasion so the virus can successfully reach host cells in the body. Therefore, a significant ROS-mediated reduction in the viral spike protein's glycosylation before exposure to the host could make the virus less infectious and more easily destroyed by the host's immune response. Preemptive modification to SARS-CoV-2 oligosaccharide moieties could be achieved through [45, 46] . They demonstrated that TiO 2 NPs cause membrane destruction to inactivate of influenza and Newcastle disease virus; an action which may be transferable to SARS-CoV-2, given that all are enveloped RNA viruses with similar structures.

Preliminary research [51] seems to support this possibility.

The virucidal action of TiO 2 nanoparticles against human norovirus and norovirus surrogates, in addition to enveloped viruses, is another particularly promising development. Noroviruses possess high genetic variability and a rapid mutation rate that makes vaccine development highly challenging while limiting 265 the duration of immunity for recovered persons. In addition, the low infectious dose of 18 viral particles or less [52] , an alcohol sanitizer-resistant non-enveloped structure [53, 54] , and ability to survive for up to several weeks on surfaces [55] , results in potent transmissibility [56] . Therefore, enteric viruses are similar to SARS-CoV-2 with respect to their environmental stability, ability to survive for 270 prolonged durations on cross-contaminated surfaces [11] , and rapid mutation.

Thus, rapid disinfecting methodologies that can stem the spread of both enveloped and non-enveloped virus domains in vulnerable environments such as hospitals and restaurants would be a major breakthrough.

The use of zinc oxide as an antiseptic may trace as far back as 4000 years to ancient Egypt when it was used in ointments to treat infected hair follicles in the form of boils and carbuncles [57] . Modern science has confirmed that ZnO and its nanoparticles (ZnO NPs) possess antibacterial properties against an extensive range of microorganisms, including Escherichia coli, Pseudomonas 280 aeruginos, Klebsiella pneumonia, Pseudomonas vulgaris, and Campylobacter jejuni [58, 59] . At the same time, zinc oxide, even in nanoparticle form, is consid-13 J o u r n a l P r e -p r o o f ered safe for human contact, as it is utilized in sunscreens, and even consumed as a supplement in zinc fortified foods [60, 61] . This is particularly because the toxic e↵ects of ZnO NPs, bulk ZnO, and Zn 2+ are similar, unlike many other 285 systems [62] . The toxicity of ZnO to pathogens and minimal impact on human cells has led to applications of nanoscale ZnO for lining food packaging and plastics to confer antimicrobial activity against foodborne and infectious pathogens [63] . In regards to food packaging, zinc oxide has been successfully integrated with petroleum-based and biodegradable PHBV polymers to improve food shelf-290 life and safety, using methods such as melt mixing, electrospinning or solvent casting [64] . Zinc oxide NPs are a leading virucidal candidate for therapeutic and surface coating applications given their unique attributes of low cytotoxicity to human cells, ROS-generating photocatalysis, and proven e↵ectiveness at damaging lipid membranes through di↵usion and accumulation.

The unique chemical properties of ZnO NPs compared to their bulk form, as with most NP systems, results from their high specific surface area, leading to greater activity against pathogens. Against bacteria, ZnO NPs can act through a mechanism of destructive di↵usion through the cell membrane, which causes lysis [59] . For instance, Xie et al. used SEM imaging to study the impact of 300 0.5 mg/L ZnO NPs on Campylobacter jejuni [63] . They found that the bacteria changed from their usual spiral shape to a coccoid morphology with instances of membrane penetration and rupture ( Figure 5 ) [63] . The images suggest that ZnO NPs accumulate on and compromise the lipid membrane to inactivate the bacteria. From across the literature, ZnO NP biocidal activity is generally 305 observed to improve with decreasing particle size, a↵ording greater e↵ective surface area [65] .

Furthermore, ZnO has a similar band gap to TiO 2 and can also act as an e↵ective, low-cost photocatalyst in the presence of water and sunlight or artificial UV [66] . ZnO NPs have been reported by groups such as Premanathan et al. 310 and Ong et al. to undergo UV photocatalysis pathways that generate excess ROS such as superoxide, hydroxyl radicals, and hydrogen peroxide [66, 67] .

As seen in TiO 2 photodegradation, these ROS can cause oxidative stress and 14 J o u r n a l P r e -p r o o f . lipid peroxidation that damages biological membranes and may induce apoptosis [24, 41, 67] . Zinc ions have also been demonstrated to exhibit virucidal e↵ects 315 on viruses through protease inhibition and disruption of viral RNA polymerase [68] . Inactivation by ZnO NPs, like other metal nanoparticles, benefits from increasing exposure time and concentration. and sprays that target viruses and bacteria while remaining safe for people.

One method of creating a stable, biocompatible coating is the use of hydrogel polymers mixed with ZnO NPs, as reported by Schwartz et al [69] . The coating developed is an antimicrobial composite hydrogel formed by mixing poly(N-isopropylacrylamide) with zinc oxide nanoparticles. SEM imaging of 325 the resultant film showed an even distribution of ZnO NPs that was highly effective in entirely disabling E. coli at a low zinc oxide concentration of 1.33 mM.

The composite coating was also found to be safely non-toxic during seven days of exposure to mammalian NIH/3T3 cells. The researchers propose that the demonstrated coating could be employed for self-sterilizing biomedical devices pathogenesis [70] . HSV-1 possess positively charged envelope glycoproteins that electrostatically bind to negatively charged heparan sulfate (HS) areas on the cell surface to induce filopodia-like structures that enable viral entry [71] .The researchers targeted this entry mechanism using ZnO MNSs, which resemble Another approach uses polymer functionalization of ZnO NPs such as with polyethylene glycol (PEG) to provide greater stability, lower toxicity, and controlled release antiviral action. Gha↵ari et al. [74] and Tavakoli et al. [75] 375 explored this option for H1N1 influenza virus, and for herpes simplex virus [75] , though confirmation requires quantitative protein expression measurements. PEGylation of the nanoparticles was achieved by mechanical ball milling, which also 390 created smaller nanoparticles. This decreased size is also a possible mechanism of increased antiviral activity since the smaller NPs are expected to be more reactive with a greater surface area to volume ratio and greater facilitated diffusion [74] . Overall, coating the surface of ZnO NPs with polyethylene glycol can enhance antiviral e cacy and lower in vitro cytotoxicity.

Applicability to SARS-CoV-2:. Given that enveloped viruses such as SARS-CoV-2 also have a lipid bilayer outer membrane, nanoparticles could disrupt and permeate the membrane in a similar manner to the bacterial inactivation mechanism [47, 76] , and in fact this is what El-Megharbel et al. observed [73] .

Amphiphilic soap is well known to e↵ectively destroy SARS-CoV-2 virions by 400 dissolving its lipid membrane, which supports the possibility that nanoparticles such as ZnO may achieve viral inactivation by targeting the same structures [11] . The ZnO micro-nano structure morphology electrostatically targeting virions suggested by Mishra et al [70, 72] 

Iron oxide nanoparticles (IO-NPs) are a prominent nanomaterial used in biomedical applications from cancer nanotherapy to biosensors to contrast agents 415 for imaging, owing to their high biocompatibility and magnetic properties [77] [78] [79] [80] . Notably, IO-NPs can be modulated under an external magnetic field and used for drug targeting or to induce local hyperthermia for tumor treatment [81] . Their proven safety in anemia treatment has led to US Food and Drug Administration (FDA) and various European Union agency approvals [82] , which 420 combined with demonstrated antibacterial [83] and antiviral activity against influenza subtypes [84, 85] The broad spectrum e cacy against influenza subtypes was made possi-435 ble by targeting the viral envelope, which is a highly conserved component across enveloped viruses [84] . The main mechanism observed by Qin et al for influenza sub-type viruses was lipid peroxidation of the viral envelope and damage to neighboring proteins that compromised virion integrity and infectivity [84] . In this way, the nanoparticles exert lipoxidase enzyme-like activity and the Takeaway and applicability to SARS-CoV-2:. In summary, iron oxide nanoparticles exhibit a broad range of antiviral mechanisms including ROS generation, lipid peroxidation, and binding to viral surface proteins to impair attachment to host cells. The lipid membrane envelope of SARS-CoV-2 renders it vulnera-505 ble to lipid peroxidation while its integral membrane proteins can be inhibited by ROS and nanoparticle binding. By targeting the viral envelope, which is a highly conserved component across enveloped viruses [84] , or its spike pro- Further, it is proposed that IO-NPs could initiate inactivating oxidative damage to viral lipid envelopes through the generation of reactive oxygen species [88] .

This mechanism of oxidative inactivation is supported by studies with other metal nanoparticles and by Qin et al. previously where lipid peroxidation of the influenza lipid envelope destroyed virions [84] . Antibacterial and synergistic 530 antiviral activity can also be achieved when IO-NPs are utilized alongside other metal nanoparticles such as Ag-NPs, which demonstrates potential for use in general disinfectants and coatings. Iron oxide nanoparticles also exhibit good biocompatibility and the existing FDA approval means iron oxide nanoparticles could be repurposed with relative ease and haste into antiviral nanomaterials 535 for safeguarding human environments and PPE.

Silver is a noble metal with an extensive history of medical uses in many cultures and a myriad of applications in current biomedical technology. Often, these applications utilize the unique microbicidal activity of Ag, which makes 540 it an excellent sterilizing agent in wound care products, surgical devices, disinfecting filters and for protecting contact surfaces. In Japan, for example, 24 J o u r n a l P r e -p r o o f silver thiosulfate in silica gel microspheres is often integrated into plastics from children's toys to toilet seats for long-term microbicidal properties [93] . Silver derivatives such as AgNO 3 have also been used for decades in eye drops, and shown the biocidal activity of AgNPs against a range of microbes, including Salmonella enterica, E. Coli, Vibrio cholerae, and Coliform bacteria and fungi [95, 96] . Smaller particles, ⇠5nm with a narrow size distribution formed by reverse micelle techniques, were able to 100% inhibit bacteria cultures at a concentration of 3 ppm and fungi at 15 ppm after 30 minutes of exposure [96] , 570 showing the e↵ectiveness of AgNPs across a broad range of pathogens.

The binding of AgNPs to inactivate membrane proteins is also supported by research into other enveloped viruses such as hepatitis B [31] and H1N1 in- [31] . Using a real-time PCR 575 method[98] to compare the HBV DNA content from AgNP treated and untreated hepatoblastoma cells, they quantified dose-dependent viral inactivation after 48 hours of incubation. 10 nm AgNPs showed 38% inhibition at 5µM and 80% viral inhibition at 50µM, while 50 nm AgNPs showed 53% and 92% inhibition at the same concentrations, respectively. They propose that there is a high 580 binding a nity of nanoparticles for HBV DNA and extracellular virions. This direct binding, which was determined using a UV-vis absorption titration assay, could inhibit nucleotide replication through DNA damage and disable virions by membrane degradation [31] . Regarding toxicity, this study also found that larger nanoparticles (800 nm) presented significantly higher cytotoxicity in cell Kim et al. also observed such a mechanism in Ag NPs targeting influenza 600 A virus [100] . A study by Siriwardana et al. supports the ability of silver nanoparticles to bind and cleave disulfide bonds [101] . Using surface-enhanced Raman spectroscopic (SERS) measurements, they find that cysteine binds to silver nanoparticles initially through its carboxylate group before forming a disulfide [101] . This disruption of disulfide bonds would fundamentally change the protein fold of a glycoprotein and may inhibit its function in attaching to target receptors. An inactivating mechanism targeting disulfide bonds in glycoproteins would be highly relevant to combating SARS-CoV-2, which also relies on its spike glycoprotein to bind to ACE-2 receptors. with resistance to antiretroviral drugs [25] . When compared to the antiretrovirals, which each target only a particular stage of the HIV life cycle such as 625 entry, retrotranscription, or gene integration, AgNPs exhibited sustained antiviral activity at every stage, suggesting broader inhibitory mechanisms. Beyond targeting of gp120-CD4 in HIV-1 to prevent cell entry, they observe that AgNPs suppress the expression of TNF-↵, an essential cytokine for HIV-1 replication that modulates proper RNA transcription [25, 94] .This suggests that AgNPs . centrations [102] . To elaborate, they found that AgNPs at a concentration of In addition to pure silver nanoparticles, bulk forms and nanoparticles of silver compounds have also been found to be functional antivirals. For instance, Du et al. examined the antiviral mechanism of Ag 2 S nanoclusters (NCs) against coronaviruses with porcine epidemic diarrhea virus (PEDV) as a model [104] . 655 The Ag 2 S NCs were produced with glutathione as a capping reagent and had an average size of 5.3 nm. After 12 hours of exposure, Ag 2 S NCs were determined to significantly suppress PEDV titers by 3 log (99.9%) in plaque assay remaining non-cytotoxic at 46 µg/mL [104] . The researchers' analysis of the antiviral mechanisms indicated that Ag 2 S NCs treatment inhibits the synthesis of viral The results substantiate the disulfide cleaving mechanism for the e↵ect of pure AgNPs [25, 101] . Further, it proves that ions sourced from nanoparticles or bulk coatings also have the ability to break disulfide bonds in glycoproteins to disrupt their function and ability to infect cells. tical and mechanical properties [110] . The e↵ectiveness of silver-infused plastics against FCV demonstrated by Castro-Mayorga et al. [110] is supported by a similar study by Martinez-Abad et al. [113] , who used solvent casting to integrate silver ions into polylactide plastic. They also found that after 24 hours of exposure, FCV was reduced by 2 log TCID50/mL on 0.1% silver films and fully 725 inactivated on 1% silver films [113] . Thus, the use of silver for antiviral polymers is possible with potential applications in custom packaging and contact surfaces.

Another approach to an antiviral environment was conducted by Park et al., ing cells. In the latter, silver is involved in aerobic reactions that generate free radicals, which in turn, causes oxidative damage to viral biomolecules [116] .

Further, another study conducted by their group found that Ag-MHCs caused with low cytotoxicity [117] . They found that silver nanoparticles conjugated with sulfur groups in viral proteins to break disulfide bonds while the negatively charged graphene oxide interacted with positively charged lipids in enveloped viruses to cause membrane rupture. Therefore, the antiviral activity of the 755 composite was enhanced relative to each component on their own [117] .

Takeaway and applicability to SARS-CoV-2:. Silver was among the most stud- 

The first recorded use of copper for its antimicrobial properties is found in 785 the Smith Papyrus, an Egyptian medical text dated between 2600 and 2200 B.C [122] . It records how people discovered copper's utility in sterilizing chest wounds and storing safe drinking water. In the 19th century, copper's medical potential became more widely recognized by the observation that copper workers were far less susceptible to cholera in the 1832 and subsequent outbreaks 790 in Paris, France [122] . Since then, scientific research into copper has enabled a 33 J o u r n a l P r e -p r o o f more complete understanding of the mechanism for copper as a natural microbicide, and it has become an important metal with many applications such as sterile touch surfaces and medicines [122] [123] [124] [125] . In contrast to other nanoparticle materials such as gold, silver, and silica, copper is an essential trace element for 795 regular metabolism in the human body, which makes it safe in the small dosages that might be used in Cu nanoparticle-based surface coatings [126] . Copper and several of its compounds are now promising candidates in nanomaterials research, given their versatility, availability, and relatively low toxicity. This section highlights several notable studies into the antiviral potency of copper-800 based nanoparticles.

Copper(I) Iodide. Cuprous iodide nanoparticles of various diameters have been studied for their antiviral activity against a strain of H1N1 influenza [127] and feline calicivirus (FCV) [128] . Cuprous iodide was chosen for its stability, and white colour that can be easily integrated into masks, filters, and other surfaces 805 without the black-brown discolouration associated with other copper compounds [127] . CuI of 160 nm was found to present significant viral inhibition against influenza with increasing nanoparticle dose with a 50% e↵ective concentration HA, hemagglutinin; NAneuraminidase; M1, matrix protein. Reproduced from Ref. [127] with permission from American Society for Microbiology. exposure to CuI NPs reduced infectivity of FCV to Crandell-Rees feline kidney (CRFK) cells by 6 log (99.9999% reduction) when exposed to a concentration of 100 µg/mL and reduced below the lower detection threshold of plaque assay at 1000 µg/mL CuI nanoparticles ( Figure 10 ) [128] . Further, CuI nanoparticles 825 were compared to a CuCl 2 · 2 H 2 O solution generating Cu + 2 ions alone, and the nanoparticles were found to have superior antiviral activity.

Electron spin resonance (ESR) spectroscopy was used to determine the mechanism of viral inactivation by CuI NPs [127, 128] , which showed that CuI NPs 35 J o u r n a l P r e -p r o o f dissociate into Cu + and generate highly reactive hydroxyl radicals (OH) in 830 phosphate-bu↵ered saline. Such ROS are known to cause oxidative damage to biological molecules resulting in nucleic acid mutations and random amino acid modifications [39, 40] reactions are also known to contribute to viral inactivation [131] , and could be a mechanism for influenza deactivation. For FCV, amino acid oxidation within the viral capsid proteins was confirmed by nano LC-MS analysis [128] . Therefore, the mechanism of inactivation for non-enveloped viruses appears to be predominately NP generated Cu + ions reacting to produce ROSs that inflict 845 oxidative damage to the protein capsid [127, 128] .

As respiratory viruses, influenza and coronaviruses share structural characteristics such as a lipid envelope with spike glycoproteins that bind target cells. Thus, with demonstrated impairment of influenza and viral proteins, it is possible that CuI nanoparticles will exert similar antiviral e↵ects against SARS- µM NP concentration. At ten times higher concentration of 0.83 µM, the NPs were able to achieve 100% inactivation of the VLPs after 10 minutes. In addition to concentration, contact time was found to be a key factor in antiviral e↵ectiveness, with the lower 0.083 µM NP dose also achieving 100% VLP inactivation after 60 minutes. Subsequent analyses with Western blot and dynamic 865 light scattering showed a 86%-95% reduction of a 32 kDa P domain protein and a decline of average particle size from the 38 nm size of VLPs before treatment to fragments of <10 nm after NP exposure, respectively (Figure 11(a) ).

These results suggest that Au@CuS NPs caused the breakdown of VLP proteins into smaller fragments. TEM imaging of the VLPs supported this conclusion as 870 physical degradation and capsid rupture was observed after NP contact. (Figure   11 (b))

The authors proposed mechanisms including contact binding, which compromises the VLP capsid integrity and di↵usion of NPs or Cu 2+ ions across the viral capsid. In the latter case, the NPs and Cu 2+ are proposed to cause RNA 875 and protein damage through chemical reactions that induce ROS formation.

other Cu-based NP studies [127, 128, 134, 135] . Though the nanoparticles in the Broglie et al study were synthesized by a two-step method by first growing gold NPs using a seeded growth method and then coating these cores with CuS 880 nanoshell [136] , they suggest that the CuS shell is most likely the active component and that the gold core could be substituted or even pure CuS nanoparticles could be used instead with similar e↵ectiveness [132] . • ROS generation by free copper ions released from the nanoparticles, which precipitate inactivation via oxidation for loss of envelope or capsid integrity, and degradation of the viral genome [138] , with denaturation of DNA and damaged cell integrity [134] .

• Damage to viral proteins through the breakage of disulfide bonds, which 895 are essential for proper protein folding and function [106] . (Figure 12a ). Compared to the control, qRT-PCR also found that HCV RNA levels were reduced by 18%, 88%, and 90% following 910 Cu 2 O-NP doses of 1, 2, and 4 µg/mL respectively (Figure 12b ). Finally, when HCV core protein expression was analyzed by western blot assay, the Cu 2 O-NP concentrations that e↵ectively inhibited HCV RNA levels also caused reductions in viral core proteins, suggesting degradation by the NPs (Figure 12c ) [139] .

When analyzing the antiviral mechanism with a time of addition assay, the 915 researchers found that Cu 2 O-NPs did not prevent the later stage HCV replication within cells but rather interfered with the early steps of the attachment and fusion of infectious virions into hepatic host cells. Therefore, the determined mechanism is that Cu 2 O-NPs with larger diameters than the HCV virions (> 60 nm) inhibit virus-cell binding by polyvalent binding of virions [139] . Since 920 HCV is an enveloped virus, it utilizes glycoproteins on its surface envelope to bind specific receptors on the host cell [140] [141] [142] [143] . was able to reduce bacteriophage Q infectivity by five orders of magnitude (99.999% reduction) within 30 minutes while CuO coated glass was not able to achieve a significant reduction in the same time frame [146] . Further, the 960 antiviral e↵ect of Cu 2 O against bacteriophage Q was found to exceed that of silver ions from a silver-powdered glass substrate. The proposed mechanism is that direct contact with the surface of solid-state cuprous compounds causes more e cient denaturation of biomolecules in viruses, but the di↵erence with CuO is not fully explained [146] . 965 Minoshima et al. also found that Cu 2 O is a more e↵ective antiviral than CuO against both enveloped influenza A and non-enveloped bacteriophage [106] .

Against titers of influenza glycoproteins, neuraminidase and especially hemagglutinin, solid-state cuprous oxide (Cu 2 O) was able to significantly degrade the proteins within 30 minutes based on red blood cell and chemiluminescence as- (c) Level of fluroescence, corresponding to total thiol (R-SH) from trypsin inhibitor protein, after incubation with di↵erent copper and silver compounds. Incubations were carried out for 4 h with each compound suspension (2.8 mmol). A control without compound was included.

Adapted from Ref. [106] , with permission from Elsevier. folding and function [106] . Using monobromobimane fluorescence of a trypsin inhibitor model protein in phosphate bu↵er to detect thiol concentration [107] , they found that CuO did not a↵ect the thiol concentration, Cu 2 O was able 985 to reduce fluorescence by half suggesting weak but still present interactions with disulfide bonds, and water-soluble CuCl 2 with dissociated into copper ions showed significantly reduced fluorescence, indicating the breakage of disulfide bonds in the trypsin model protein [106] . It is suggested that copper denatures proteins by cleavage of disulfide bonds similar to the mechanism for sil- as antiviral biodegradable polymers [110, 147] . In an antiviral assay against 1005 murine norovirus [111, 112] , the 0.1% and 0.05% nanoparticle films achieved 1.83 and 3.19 log TCID50/mL reductions of viral infectivity, respectively [147] .

After MNV was exposed to the coated complex for a full 24 hours at 25°C, no infectious virus was detected.

Borkow et al. [148] examined the potential of copper-based nanoparticles for 1010 a self-sterilizing antiviral face mask by impregnating Cu 2 O NPs into a 4 layer N95 mask following established methods [149, 150] . The mask was exposed to H1N1 in a simulated breathing apparatus, and no infectious virions were though the data was unpublished [127] . The potent antiviral action of CuI NPs against influenza and feline calicivirus suggest that they could also be similarly incorporated into masks, protective equipment and surfaces. teraction, and competitive inhibition of receptors [127, 128, 132, 135, 139] . In contrast to the optimal sizes for silver and zinc nanoparticles, the size range for e↵ective copper nanoparticles against enveloped viruses in the literature (40- 160 nm) was found to feature larger nanoparticles on average [127, 135, 139] .

In regards to real-world applications, copper is generally considered safe for hu-1035 man contact, being non-irritating to the skin and, unless consumed, is highly non-cytotoxic [151] . Therefore, the element has been incorporated into antimicrobial fabrics, polymers, and self-sterilizing PPE [147, 148, 150] , some of which have achieved FDA or US government Environmental Protection Agency (EPA) 45 J o u r n a l P r e -p r o o f [152] [153] [154] and already exist as commercial products [155, 156] .

Throughout the discussed studies, oxidative damage to biomolecules caused by ROS is a common antiviral mechanism of copper nanoparticles. The generation of ROS, including hydroxyl radicals, is facilitated by copper as a catalyst in Fenton and Haber-Wiess like reactions [127, 129] . Hydroxyl radicals will rapidly bond with biomolecules to resolve unpaired electrons resulting in lipid peroxida-1045 tion, protein misformation, and genetic damage. As a lipid enveloped RNA virus with spike and capsid proteins, SARS-CoV-2 is susceptible to oxidative damage from copper nanoparticles and ROS [47, 76] . Furthermore, the copper and free radical antiviral mechanism can also specifically target the oligosaccharide glycosylation on the SARS-CoV-2 spike protein. Eguchi et al. demonstrated in 1050 their study that the free radical products of copper ions and hydrogen peroxide are able to cleave glycosidic linkages [157] in oligosaccharides monomers as well as those in glycoproteins in a hepatitis rat model [49] . Specifically, using reversed-phase high performance liquid chromatographic analysis, they found that free radicals destroyed the N-acetyl group in N-Acetylglucosamine (Glc- susceptible to antibodies [158] . Furthermore, the demonstrated ability of copper ions to break disulfide bonds is applicable to SARS-CoV-2, which has S-S bonds that maintain the proper fold of its spike protein [106, 120] . The virucidal action of various Cu based nanoparticles, similar to TiO 2 , 1080 against human norovirus and norovirus surrogates [128, 132, 147] , as well as enveloped viruses such as influenza, could be another pathway to broad spectrum disinfecting surfaces. Rapid disinfecting approaches that disable both enveloped and non-enveloped virus domains would be a major breakthrough. With EPA approval of copper surfaces for use against coronovirus [153] , and incorpora-tion of copper compounds into commercial textile products, further study of Cu-based NPs is critical to examine inactivation e cacy for SARS-CoV-2 and stability for applications in self-sterilizing surfaces.

Gold is a metal known for its stability, inert biocompatibility, and tendency cell survival. This substantial disparity in e cacy was attributed by the authors to multivalent e↵ects causing the binding forces between viral surface proteins and larger AuNPs to be stronger [162] . TEM imaging was conducted 1145 of influenza virions incubated with 14 nm AuNPs, and the nanoparticles were shown to readily attach to surface structures such as the hemagglutinin spike protein ( Figure 19 ) [161] . The mechanism of viral inactivation is described as blocking the sialic acid receptor-binding between influenza and its target cells, which stops the fusion step of influenza pathogenesis. This paper demonstrates greater contact area and more interaction sites by which to attach and disable VSV virions. Although less e↵ective, the smaller 19 nm nanoparticles were still able to reduce VSV infectivity by preventing its binding to its cellular target, 1165 namely low-density lipoprotein receptors [164] . The prominent finding from this study is that polysulfated gold nanoparticles inhibit VSV cell infection through a mechanism strongly-dependent on particle size. 

Given the action of various nanoparticles through di↵erent mechanisms of virus inactivation, a promising approach is to produce hybrid surfaces with more than one type of particle to increase the e cacy in self-sterilization. Hodek et 1215 al., for example, developed a hybrid surface coating containing silver, copper and zinc cations with the goal of combating viral transmission through contaminated surfaces [168] . The surface coatings were produced through radical polymerization via a sol-gel method and spread on glass slides or into the wells of polymethylmethacrylate(PMMA) plates. To test viral inactivation, the coated 1220 glass slides or PMMA plates were exposed to 10 µl droplets of several viruses such as human immunodeficiency virus type 1 (HIV-1), influenza, dengue virus, herpes simplex virus, and coxsackie virus before incubation for 5 to 240 min.

These slides were then sampled and compared against virus samples on the equivalent uncoated control during titer determination of recovered virus [168] 1225

Using SEM imaging to measure the coatings' morphology, the researchers found superior adhesion to the glass slides. Consequently, the HIV-1 titer was reduced by a substantial 99.5100 % after only 20 minutes of exposure to the coating on glass. On PMMA plates, the inactivation was 75%-100% after 20 minutes and 98%-100% after 120 minutes. The inactivation of other viruses 1230 was slower on the surface coating with 240 minutes of exposure achieving 97 % (dengue), 100 % (herpes simplex) and 77 % (influenza) reduction in virus titers [168] . The coating was less e↵ective against the non-enveloped coxsackievirus with only marginal reductions after 4 hours. The researchers observed that the overall properties of the hybrid surface coating depended more on the sol syn-1235 thesis and curing methods than the substrate. For instance, the coatings cured at 150°C were thinner than those cured at 90°C, while heat polymerization created better mechanical properties than photopolymerization. Cytotoxicity is an essential consideration for surface coatings that may be used in human environments. Even though Ag + , Cu 2+ , and Zn 2+ ions are generally more cy-1240 totoxic than their corresponding nanoparticles, the hybrid coating in this study was found to be safe with minimal viability impact on Vero and HeLa cells [168, 169] . Through repeated washings, the researchers did not find significant leaching of the metal ions suggesting that the coating stably releases ions at a rate that produces virucidal activity while being safe to human cells.

The proposed antiviral mechanism is the release of ions from the coating, including Ag + , Cu 2+ , and Zn 2+ , that react with and damage virions. As dis- [25, 94] . Copper ions may also contribute to binding disulfide bonds and cysteine residues to denature 1260 viral glycoproteins as demonstrated by Minoshima et al. [106] . Furthermore, the complete inactivation of herpes simplex virus suggests that silver may also disrupt its double-stranded DNA due to its high binding specific a nity. This mechanism was also reported by Lu et al. for silver nanoparticles against hepatitis B virus where DNA replication processes were inhibited to cease viral 1265 infectivity [31] .

Finally, the small impact of the hybrid coating on the non-enveloped coxsackie virus suggests that the antiviral mechanism of metal ions is primarily driven by interactions with the viral envelope and surface structures such as glycoproteins [168] . Thus, this coating design would target the enveloped viruses, system leveraged the strengths of both silver and iron oxide to achieve disinfection e cacy against E. coli and MS2 phage that was greater than either material alone. It should be noted that using metal nanoparticles together may also reduce the risk of pathogen resistance given the multiple inactivation mechanisms [91] . as the bacteria model, the Cu X O/TiO 2 composite coating exposed to water and UV light achieved a >9 log reduction after 80 minutes, which was higher than 1295 the films of only TiO 2 or copper oxides [171] . The virtually complete inactivation of pathogens suggests that TiO 2 photocatalysis and the reaction pathways of copper may act synergistically to disable viral suspensions. The combination of free radicals from TiO 2 and solid-state contact killing from copper likely combine to provide a more e cient inactivation mechanism than either substance 1300 alone. Furthermore, copper can generate ROS as well through Fenton-like reactions that require hydrogen peroxide and superoxide as intermediates [127] . When the researchers retested the PEI slide with a higher initial concentration of influenza, plaques were still not observed, which indicates a reduction in viral infectivity of at least 10,000 times (4 log) [172] . To further determine to polyethylene and polypropylene substrates in addition to glass and found that PEI thoroughly disinfected influenza solutions regardless of the surface it is on [173] . Further, PEI coatings were tested against a broader range of influenza viruses, including avian pathogenic wild-type and mutant zanamivir-1335 resistant strains and again, complete inactivation of these strains was achieved.

The inactivation was confirmed by ELISA and SDS-PAGE analysis of the PEIexposed viral solutions, which indicated the disappearance of viral particles from solution and a 94% reduction in influenza proteins [173] . This disappearance provides clues as to the specific mechanism of PEI in disabling enveloped viruses While viruses may be able to develop specific resistances through a limited 1360 number of mutations in response to a traditional antiviral drug, the probability of being able to concurrently develop multiple resistance mutations that directly counter the multiple mechanisms of a metal-based NP is unlikely [27, 174] . Different NPs could attack viruses through diverse pathways such as oxidative stress, protein disruption, as well as lipid envelope and capsid damage [27] . For 1365 instance, the common mechanism of reactive oxygen species production circumvents bacterial and viral resistance by simultaneously damaging multiple targets 59 J o u r n a l P r e -p r o o f on the pathogen and compromising its integrity [38, 42, 175] . The ability to treat resistant pathogens is a significant advantage of nanoparticles over antiviral and antibiotic drugs which often target one component of a pathogen and thus are 1370 susceptible to resistance [25, 139] . In addition to antiviral activity, the antibacterial properties of metal nanoparticles provide utility in thoroughly sterilizing environments and may reduce the risk of secondary bacterial infections caused by COVID-19 [176] .

Further, the physicochemical properties of metal nanoparticles can be more 1375 finely controlled by modifying their size and surface functionalization compared to organic lipid or polymer-based NPs [177] . These advantages in microbicidal activity are complemented by the practical benefits of long-term stability of metal nanoparticle products and their relative ease of manufacturing [178] . The chemical and colloidal stability of metal nanoparticles makes them viable for ap-1380 plications where sustained activity is needed such as surface coatings, sterilizing sprays, biomedical products, and reusable fabrics [179] . Metal nanoparticles can also be produced in a cost-e↵ective manner with a range of techniques from green synthesis to electric plasma discharge to reverse micelle deposition [26, [180] [181] [182] [183] [184] [185] .

Compounds such as titanium and zinc oxides exhibit unique optical properties 1385 such as generating antiviral ROS upon exposure to UV-wavelengths; therefore, their incorporation would synergize well with UV disinfection regimes and sunlit environments [43, 114] . Finally, the magnetic properties of metal compounds such as iron oxides enable the targeting of nanoparticles and enhanced recovery from the environment to minimize pollution using magnetic field manipulation 1390 [80, 81, 114] .

Disadvantages and Considerations:. Although metal nanoparticles hold significant potential for combating SARS-CoV-2 and other viruses, there remain limitations that must be considered. For instance, it is challenging to produce nanoparticles at industrial scale and di cult to synthesize pure and uniform 1395 batches [186] . Consistent reproducibility is important as batch-to-batch variation in nanoparticles can lead to unforeseen changes in physicochemical and 60 J o u r n a l P r e -p r o o f pharmacokinetic properties [187] . Increasing the complexity of nanoparticle systems with multiple drug encapsulation or surface ligands will require multiple production steps and further the di culty of large-scale manufacturing 1400 [188] . Additionally, in therapeutic and imaging applications, many nanoparticle products have been unable to fulfill the promise of selective targeting to specific tissues and further development is needed for ligand-mediated targeting [189, 190] .

The most significant limitation that must be considered is the safety and cy-1405 totoxicity of such materials. Nanoparticles typically have higher toxicity than bulk materials given their small size and ability to penetrate biological membranes which could lead to persistence in multicellular organisms, if exposure is long term and in high concentrations [191] . Nanoparticles with virucidal mechanisms, particularly reactive oxygen species generation, pose a risk of damage 1410 to not only viruses, but also human cells if left unregulated in close proximity.

If used in vivo, metal-based NPs can pose a risk of accumulation and toxicity to tissues and organs, as some are non-biodegradable by enzymes in the body.

Thus, it is important to design nanoparticles from a safety perspective that prioritizes biodegradability or optimized clearance from the body [192] .

Non-metallic nanoparticles, such as those composed completely of polymers or integrating lipids and cell membranes, usually exhibit superior biocompatibility [193, 194] . An alternative to metal nanoparticles for viral inhibition are nanosponges made up of nanoparticles with a poly-lactic-co glycolic acid (PLGA) core coated in either human lung epithelial type II cell or macrophage 1420 cell membranes [194] . Incorporating human cell membranes that are natural targets of SARS-CoV-2, such biomimetic decoys can competitively bind the virus.

Zhang et al. [194] showed that these nanosponges can attract and sequester SARS-CoV-2 to prevent host cell entry, by displaying the same receptors that the virus uses for infection. E cacy was dose-dependent and a concentration 1425 of 5 mg/mL caused SARS-CoV-2 infectivity inhibition of 88%-93% with good safety when administered to lungs in mice. Importantly, the e↵ectiveness of cell membrane-coated nanosponges may be resistant to viral mutations as all known 61 J o u r n a l P r e -p r o o f SARS-CoV-2 variants target the same host cells to initiate infection [194] . With the use of respiratory cell membranes, it is also possible that nanosponges could 1430 broadly inhibit other respiratory viruses which infect the same cells. Although promising in vivo, it remains to be seen if nanosponges can be utilized in applications outside the body. It is, however, possible to decrease the cytotoxicity and secondary e↵ects of ROS-associated oxidative damage to healthy cells. The size of nanoparticles 1435 plays a role in their safety, with larger nanoparticles (>100 nm) generally exhibiting lower cytotoxicity than smaller nanoparticles [195, 196] . However, there is often a trade-o↵ in e cacy as smaller particles tend to have greater anti-viral potency [25, 27, 65, 74, 94-97, 102, 110, 119] . However, for some particles such as Ag, smaller sizes exhibited lower cytotoxicity possibly due to their ability to 1440 more easily bind virions [27] . Therefore, careful studies on the e↵ect of nanoparticle size on both anti-viral activity and cytotoxicity need to be undertaken.

Biocompatible coatings and surface modifications with polymeric compounds such as polyethylene glycol or polyvinyl pyrrolidone also reduce cytotoxicity by preventing nuclear condensation and bioaccumulation [74, 75, 90, 161, 163, 195] . Although the safety of nanoparticles is an important consideration, when they are properly embedded in surfaces and polymers to confer antiviral prop-1450 erties, nanotoxicity is less of a concern given the reduced likelihood for NP entry into the human body compared to NP applications such as drug delivery. Nevertheless, the potential toxicity of metal nanoparticles must be considered and further investigated with applications such as facemasks and other PPE where inhalation and close contact may provide routes of NP entry into the body.

These safety considerations also give rise to significant regulatory hurdles for any potential nanoparticle products [188, 197] .

Although there have been few direct studies exploring SARS-CoV-2 inactivation by nanomaterials due to its recency, the many antiviral mechanisms 1460 observed for other viruses can be analyzed for applicability to the novel coronavirus based on shared characteristics.

First, the generation of excess ROS is a broad biocidal mechanism exhibited by many metal oxide particles, such as TiO 2 and ZnO nanoparticles through UV photocatalysis [24, 41, 43, 66, 67] or directly from iron oxide and Cu based 1465 materials [84, 85, 131, 138] . Throughout the studies reviewed, ROS such as hydroxyl radicals have been demonstrated to destructively bind with biomolecules in the process of resolving their unpaired electrons. This mechanism causes oxidative damage to the lipid membranes, protein capsids, and genetic material of viruses that impairs their ability to enter hosts and replicate [38, 39, 41, 42, 84] . [24] . Additionally, studies such as that by Fujimori et al. demonstrate that copper-based nanoparticles such as CuI NPs can partake in Fenton-like reactions that generate ROS [127] . These free radicals were shown to e↵ectively degrade the hemagglutinin and neuraminidase glycoproteins that influenza uses to bind its host cells. Abo-zeid et al recently showed that iron oxides are predicted 1480 to directly interact with S1-RBD on the SARS-Cov-2 spike protein, leading to irreversible conformational changes that would prevent viral binding [88] . As respiratory viruses, influenza and SARS-CoV-2 both utilize spike glycoproteins to infect similar host cells [158] . Therefore, the observed degradation of influenza glycoproteins by metal generated ROS could also result in the inactivation of 1485 SARS-CoV-2's main virulence mechanism.

On the topic of glycoproteins, ROS catalyzed by nanoparticles can also cause the cleavage of oligosaccharides from glycoproteins as demonstrated by Yasuda et al. and Eguchi et al [49, 157] for Cu and by Kumar et al [85] for Fe. Notably, for Cu compounds, the hydroxyl radicals generated by copper ions in Fenton-1490 like reactions could break N-linked glycosidic linkages at N-Acetylglucosamine (GlcNAc) residues [49, 157] . GlcNAc residues attach oligosaccharides of the glycan shield to the spike protein, which suggests that nanoparticle generated ROS can influence deglycosylation of SARS-CoV-2 via cleavage of these oligosaccharides [1, 34, 158] . The SARS-CoV-2 spike protein depends on its to cysteine residues as a thiolate before eventually replacing the S-S bonds between cysteines with S-Ag bonds [101] . Minoshima et al. substantiated this mechanism and demonstrated that Cu 2+ ions could undergo the same pathway to disrupt disulfide links in influenza glycoproteins [106] . Nangmenyi et al. [91] showed significant broad spectrum activity against both bacteria and viruses 1535 by producing a hybrid material composed of Ag-modified iron oxide nanoparticles. Since disulfide bridges are crucial to the tertiary and quaternary structure of proteins, the formation of cysteine-silver complexes would change the fold of the glycoprotein, which could inhibit its ability to complete host cell attachment and fusion. The disulfide bonding mechanism may not be solely limited to metal 1540 cations as the hybrid surface coating developed by Hodek et al., which also released zinc ions, was e↵ective against HIV-1, influenza and dengue virus, all of which feature disulfide bridges between cysteine in their glycoproteins [168] . can also be easily functionalized with polymers such as polyethylene glycol on their exterior to provide lower cytotoxicity, stability, and improved virucidal characteristics [74, 90, 161, 163] . By inhibiting herpes simplex virus, influenza, and measles virus, which all share the same fundamental envelope structure with SARS-CoV-2, it can be inferred that the metal nanostructures would re-1555 main e↵ective against the novel coronavirus [26, 70, 161] , as shown explicitly for iron oxides by Abo-zeid et al. [88] .

Finally, nanoparticles of zinc oxide, iron oxide, silver, and copper have also been demonstrated using SEM and TEM to directly interact with and compromise bacterial membranes [59, 63, 64, 84, 110, 122, 138] . This occurs through the 1560 di↵usion of nanoparticles and metal ions through the membrane, which causes cell death by lysis [59, 63] . Given that both cell membranes and viral envelopes are based on the same lipid bilayer structure, it can be inferred that nanoparticles smaller than individual virions could act with a similar bilayer penetration 66 J o u r n a l P r e -p r o o f mechanism to cause viral inactivation through damage to the envelope. On 1565 the topic of the envelope as an antiviral target, PEI-based polycationic coatings exhibit potent destruction of influenza through envelope rupture and RNA leakage within minutes of contact [172, 173] . Further, iron oxide nanoparticles can catalyze lipid peroxidation of viral envelopes to compromise their integrity while degrading surface proteins [84] . With a lipid envelope encasing a central 1570 core of its RNA, SARS-CoV-2 would also be vulnerable to these mechanisms.

Combining nanoparticle approaches with polycationic coatings could result in highly e↵ective self-sterilizing surfaces through immobilization and lysis.

In summary, metal and metal oxide nanoparticles may work to disable SARS-CoV-2 early in its pathogenesis by targeting its spike proteins through com-1575 petitive inhibition or disulfide cleavage to prevent the virus from entering and infecting cells. Further, direct physical damage to viral membranes of enveloped viruses such as SARS-CoV-2 is exhibited by many nanoparticles due to their high specific surface area and small size. Titanium dioxide, zinc oxide, iron oxide, and cuprous compounds have been proven to inactivate viruses in solid-1580 state surface coatings or in polymers with a high degree of e↵ectiveness. Notably, these compounds share the blanket antiviral pathway of ROS generation to degrade essential viral structures and deglycosylate spike proteins. Therefore, ROS generating nanomaterials are optimal prophylactic agents for self-sterilizing surface coatings and polymers. These are summarized in Table 1 and Figure   1585 23. 

Original figures were created with BioRender.com. We gratefully acknowledge the financial support of the Ontario Ministry of Research and Innovation (Early Researcher Award ER15-11-123 for AT), the Natural Science and Engineering Council of Canada

Xi Grants-in-Aid-of-Research (NS)

Vulnerabilities in coronavirus glycan shields despite exten-1625 sive glycosylation

Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?

A materials-science perspective on tackling COVID-19

Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis

Next generation deep sequencing and vaccine design: Today and tomorrow

1645 mRNA vaccine delivery using lipid nanoparticles

Sensitive, Rapid, Low-Cost, and Multiplexed COVID-19 Monitoring by the Wireless Telemedicine Platform

Applications of gold nanoparticles in virus detection

Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal 1655

Aerosol and sur-1660 face stability of SARS-CoV-2 as compared with SARS-CoV-1

Stability of SARS-CoV-2 in di↵erent environmental conditions

Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in 1675 destination: Successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface

Can the coronavirus disease be transmitted from food? A review of evidence, risks, policies and knowledge gaps

COVID-19 rarely spreads through surfaces. So why are we still deep cleaning?

Low 1685 risk of SARS-CoV-2 transmission by fomites in real-life conditions

Insights from nanotechnology in COVID-19 treatment

Nanotechnology-based disinfectants and sensors for SARS-CoV-2

Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism

Ghaffarieh, An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: An in silico approach

Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase

Comparison of Infectious Agents Susceptibility to Photocatalytic E↵ects of Nanosized Titanium and Zinc Oxides: A Practical Approach

Fluorinated TiO2 as an ambient light-activated virucidal surface coating material for the control of human norovirus

Bactericidal e↵ect of silver nanoparticles against multidrug-resistant bacteria

Virucidal Activity of Gold Nanoparticles Synthesized by Green Chemistry Using Garlic Extract

Silver Nanoparticles as Potential Antiviral Agents

Chapter 1 -nanometallic particles for oligo-1740 dynamic microbial disinfection

Metal nanoparticles: The protective nanoshield against virus infection

Silver nanoparticles inhibit hepatitis B virus replication

Broadspectrum bioactivities of silver nanoparticles: The emerging trends and future prospects

Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune response

Sitespecific glycan analysis of the SARS-CoV-2 spike

Toxicity of Nano-Titanium Dioxide (TiO2-NP) Through Var-1765 ious Routes of Exposure: A Review

Generation and detection of reactive oxygen species in photocatalysis

Photocatalytic inactivation of influenza virus by titanium dioxide thin film

The Role of Reactive Oxygen Species (ROS) in the Biological Activities of Metallic Nanoparticles

Antimicrobial E↵ect of Titanium Dioxide Nanoparticles

Resistance -A One Health Perspective, IntechOpen

Analysis of Hydroxyl Radicals and Inactivation Mechanisms of Bacteriophage MS2 in Response to a Simultaneous Application of UV and Chlorine

Photocatalytic e↵ect of TiO2 films on viruses and bacteria, Plasma Process. Polym

Post-stress bacterial 1790 cell death mediated by reactive oxygen species

Antimicrobial and antibiofilm e cacy of self-cleaning surfaces functionalized by TiO2 photocatalytic nanoparticles against Staphylococcus aureus and Pseudomonas 1795 putida

Sonochemical Synthesis of Mesoporous Iron Oxide and Accounts of Its Magnetic and Catalytic Properties

Antibacterial and antiviral potential of colloidal Titanium dioxide (TiO2) nanoparticles suitable for biological applications

Interaction of titanium dioxide nanoparticles with influenza virus

Sars-CoV-2 Envelope and Membrane Proteins: Structural Di↵erences Linked to Virus Characteristics?

A Visual Guide to the SARS-CoV-2 Coronavirus

Reactive oxygen species modify oligosaccharides of glycoproteins in vivo: A study of a spontaneous acute hepatitis model rat (LEC rat

Beyond Shielding: The Roles of Glycans 1825 in SARS-CoV-2 Spike Protein

Vitro Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2

Norwalk virus: How infectious is it?

E↵ectiveness of 1835 liquid soap and hand sanitizer against norwalk virus on contaminated hands

Comparative e cacy of seven hand sanitizers against murine 1840 norovirus, feline calicivirus, and GII.4 norovirus

Persistence of human noroviruses on food preparation surfaces and human hands

Global economic burden of norovirus gastroenteritis

Medicine in the Days 1850 of the Pharaohs

Metal oxide nanoparticles as bactericidal agents

Properties of Zinc Oxide 1855 Nanoparticles and Their Activity Against Microbes

Zinc Therapy in Dermatology: A Review

Support for the Safe Use of Zinc Oxide Nanoparticle Sunscreens: Lack of Skin Penetration or Cellular Toxicity after Repeated Application in Volunteers

The Toxic E↵ects and Mechanisms of CuO and ZnO Nanoparticles

Antibacterial Activity and Mechanism of Action of Zinc Oxide Nanoparticles against Campylobacter 1870 jejuni

The impact of zinc oxide particle morphology as an antimicrobial and when incorporated in poly(3-hydroxybutyrate-co-3-hydroxyvalerate) 1875 films for food packaging and food contact surfaces applications

Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc 1880 oxide nanoparticles

A review of ZnO nanoparticles as solar photocatalysts: Synthesis, mechanisms and applications

Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation

Inhibition of HIV-1 infection by zinc group metal compounds

Antibacterial surface coatings from zinc oxide nanoparticles embedded in Poly(N-isopropylacrylamide) hydrogel surface layers

Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1

The importance of heparan sulfate in herpesvirus infection

Ultraviolet-light-assisted formation of ZnO nanowires in ambient air: Comparison of photoresponsive and photocatalytic activities in zinc hydroxide

SARS-CoV-2" and Testing Its Biological E↵ectiveness on Some Biochemical Parameters during (COVID-19 Pandemic)-"ZnO Nanoparticles Have Antiviral Activity against (SARS-CoV-2)

Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: An-1920 other emerging application of nanomedicine

Polyethylene glycol-coated zinc oxide nanoparticle: An ef-1925 ficient nanoweapon to fight against herpes simplex virus type 1

Coronavirus envelope protein: Current knowledge

Targeted Magnetic Iron Oxide Nanoparticles for Tumor Imaging and Therapy

Use of Magnetic Nanoparticles as Targeted Therapy: Theranostic Approach to Treat and Diagnose Cancer

Recent advances and future prospects of iron oxide nanoparticles in biomedicine and diagnostics

Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications

Hyperthermia: Potential and Limitations

Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

The potential anti-infective applications of metal oxide nanoparticles: A systematic review, WIREs Nanomedicine

Catalytic inactivation of influenza virus by iron oxide nanozyme

Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus

Adsorption of rotavirus and bacteriophage MS2 using glass fiber coated with hematite nanoparticles

Magnetic nanoparticles are highly toxic to -resistant Plasmodium falciparum, dengue virus (DEN-2), and their mosquito vectors

A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat 1980 and control COVID-19 infection

An in vitro analysis of H1N1 viral inhibition using polymer coated superparamagnetic Fe3O4 nanoparticles

Silver-modified 1990 iron oxide nanoparticle impregnated fiberglass for disinfection of bacteria and viruses in water

PRD1 and MS2) Attached to Iron Oxide-Coated Quartz Sand

The bactericidal e↵ect of silver nanoparticles

Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds

Silver nanoparticles as potential antiviral agents against African swine fever virus

Synthesis of nanosilver particles by reverse 2010 micelle method and study of their bactericidal properties

Inhibitory e↵ects of silver nanoparticles on H1N1 influenza A virus in vitro

Kinetics and risk of de novo hepatitis b infection in HBsAg-Negative patients undergoing cytotoxic chemotherapy

Contribution of disulfide bonds in the carboxyl terminus of the human immunodeficiency virus type I gp120 glycoprotein to CD4 binding

Porous gold nanoparticles for attenuating infectivity of influenza A virus

Studying the E↵ects of Cysteine Residues on Protein Inter-Silver Nanoparticles

Cytotoxicity and antiviral activity of electrochemical -synthesized silver nanoparticles against poliovirus

Inhibitory e↵ects of silver nanoparticles against adenovirus type 3 in vitro

Glutathione-Capped Ag2S Nanoclusters Inhibit Coronavirus Proliferation through Blockage of Viral RNA Synthesis and Budding

Interferon-induced ifit proteins: Their role in viral pathogenesis

Comparison of the antiviral e↵ect of solid-state 2050 copper and silver compounds

Studies on soybean trypsin inhibitors

Antimicrobial activity and action of silver

Four free cysteine 2060 residues found in human IgG1 of healthy donors

Antiviral properties of silver nanoparticles against norovirus surrogates and their e cacy in coated polyhydroxyalkanoates 2065 systems

Critical physiological factors influencing the outcome of antimicrobial testing according to ISO 22196 / JIS Z 2801

Background and evidence leading to the 2075 establishment of the JIS standard for antimicrobial products

Evaluation of silver-infused polylactide films for inactivation of Salmonella and feline calicivirus in vitro and on fresh-cut vegetables

Antiviral properties of silver nanoparticles on a magnetic hybrid colloid

Magnetic hybrid colloids decorated with Ag nanoparticles bite away bacteria and chemisorb viruses

Role of reactive oxygen species in the antibacterial mechanism of silver 2090 nanoparticles on Escherichia coli O157:H7

Antiviral Activity of Graphene-Silver Nanocomposites against Non-Enveloped and Enveloped Viruses

Silver nanoparticles as a new generation of antimicrobials

Interaction of silver nanoparticles with HIV-1

Structural basis of receptor recognition by SARS-CoV-2, Na-2105 ture

Antimicrobial e↵ects of silver nanoparticles

Metallic copper as an antimicrobial surface

Copper-polymer 2115 nanocomposites: An excellent and cost-e↵ective biocide for use on antibacterial surfaces

Copper and copper nanoparticles: Role in man-2120 agement of insect-pests and pathogenic microbes

Antimicrobial Nano-Agents: The Copper Age

Human whole-body copper metabolism

Novel Antiviral Characteristics of Nanosized Copper(I) Iodide Particles Showing Inactivation Activity against

Pandemic H1N1 Influenza Virus

Investigation of the antiviral properties of copper iodide nanoparticles against feline calicivirus

Reactions of low-valent transition-metal complexes with hydrogen peroxide. Are they "Fenton-like" or not? 1. The case of Cu+aq and Cr2+aq

Killing of bacillus spores by aqueous dissolved oxygen, ascorbic acid, and copper ions

A Critical Overview of the Chemistry of Copper-Dependent 2145

Low Density Lipoprotein Oxidation: Roles of Lipid Hydroperoxides, ↵-Tocopherol, Thiols, and Ceruloplasmin

Antiviral activity of Gold/Copper sulfide Core/Shell nanoparticles against 2150 human norovirus virus-like particles

Design and evaluation of three immuno-based assays for rapid detection of human norovirus virus-like particles

Inactivation of murine norovirus on a range of copper alloy surfaces is accompanied by loss of capsid integrity

Inhibition of herpes simplex virus type 1 by copper oxide nanoparticles

Local field enhanced Au/CuS nanocomposites as e cient photothermal trans-2165 ducer agents for cancer treatment

Role of herpes simplex virus 1 immediate early protein ICP22 in viral nuclear egress

Mechanism of antibacterial activity of copper nanoparticles

Antiviral activity of 2175 cuprous oxide nanoparticles against Hepatitis C Virus in vitro

Hepatitis C Viruses: Genomes and Molecular Biology

Functional hepatitis C virus envelope glycoproteins

Viral glycoproteins: Biological role and 2185 application in diagnosis

Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

Nano-Sized Copper (Oxide) on Alumina Granules for Water Filtration: E↵ect of Copper Oxidation State on Virus Removal Performance

Highly e cient antiviral and 2200 antibacterial activities of solid-state cuprous compounds

Antimicrobial nanocomposites and electrospun coatings based on 2205 poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and copper oxide nanoparticles for active packaging and coating applications

A novel anti-influenza copper oxide containing respiratory face mask

Copper oxide impregnated textiles with potent biocidal activities

Putting copper into action: Copper-impregnated products with potent biocidal activities

Copper hypersensitivity: Dermatologic aspects*

FDA Clears First Antiviral Surgical Mask

EPA Registers Copper Surfaces for Residual Use Against Coronavirus

EPA Approves Registration of Antimicrobial Copper Alloys

Cupron Reusable Face Masks -Copper Infused Reusable Face 2230

Oxidative Damage Due to Copper Ion and Hydrogen Per-2235 oxide Induces GlcNAc-Specific Cleavage of an Asn-Linked Oligosaccha-ride1

Exploitation of glycosylation in enveloped virus pathobiology

Turkevich method for gold nanoparticle synthesis revisited

Approved antiviral drugs over the past 50 years

Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles

Inhibition of HIV fusion with multivalent gold nanoparticles

Virus inhibition induced by polyvalent nanoparticles of di↵erent sizes

LDL receptor and its family members serve as the cellular receptors for vesicular 2260 stomatitis virus

Self-assemblies of plasmonic gold/layered double hydroxides with highly e cient antiviral effect against the hepatitis B virus

Negatively charged residues in the endodomain are critical for specific assembly of spike protein into murine coronavirus

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Protective hybrid coating containing silver, copper and zinc cations e↵ective against human immunodeficiency virus and other enveloped viruses

Toxicity of Ag, CuO and ZnO nanoparticles to selected en-2280 vironmentally relevant test organisms and mammalian cells in vitro: A critical review

New type of protective hybrid and nanocomposite hybrid coatings containing silver 2285 and copper with an excellent antibacterial e↵ect especially against MRSA

Photocatalytic antimicrobial activity of thin surface 2290 films of TiO2, CuO and TiO2/CuO dual layers on Escherichia coli and bacteriophage T4

Polymeric coatings that inactivate both influenza virus and pathogenic bacte-2295

Mechanism of inactivation of influenza viruses by immobilized hydrophobic polycations

The antimicrobial activity of nanoparticles: Present situation and prospects for the future

Metal oxide nanoparticles as antimicrobial agents: A promise for the future

The role of co-infections and secondary infections in patients with COVID-19

Advanced in developmental organic and inorganic nanomaterial: A review

Nanoparticle assemblies: Main synthesis pathways and 2315 brief overview on some important applications

Designed synthesis and surface engineering strategies of magnetic iron oxide nanoparticles for biomedical applications

Green and cost e↵ective synthesis of silver nanoparticles from endangered medicinal plant Withania coagulans and their potential biomedical properties

Magnetic nanoparticles: Synthe-2325 sis, functionalization, and applications in bioimaging and magnetic energy storage

Wet chemical synthesis of metal oxide nanoparticles: A review

Probing the multi-step crystallization dynamics of micelle templated nanoparticles: Structural evolution of single crystalline -Fe 2 O 3

Role of hydration and micellar shielding in tuning the structure of single crystalline iron oxide nanoparticles for designer applications

Improved hole injection for blue phosphorescent organic light-emitting diodes using solution deposited tin oxide nano-particles decorated ITO anodes

Nanoparticle Manufac-2345 turing -Heterogeneity through Processes to Products

Nanomedicines: Addressing the scientific and regulatory gap

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

Grand Challenges in Nano-Based Drug Delivery

Challenges in the development of nanoparticle-based imaging 96 f agents: Characterization and biology, WIREs Nanomedicine Nanobiotech-2360 nology

Potential Health Impact of Nanoparticles

Enzymatic oxidative biodegradation of nanoparticles: Mechanisms, significance and applications

The Design of Poly(lactide-co-glycolide) Nanocarriers for Medical Applications

Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity

Use of Coated Silver Nanoparticles to Understand the Relationship of Particle Dissolution and Bioavailability to Cell and Lung Toxicological Potential

Cytotoxicity and Immunological Response of Gold and Silver Nanoparticles of Di↵erent Sizes

Challenges in Development of Nanoparticle-Based Therapeutics

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f Highlights • Metal-based nanoparticles exert a diverse range of inactivation mechanisms, making it difficult for viruses to develop resistance • Effects of metal-based nanoparticles include free radical catalysis, binding inhibition and structure degradation to effectively disable a broad range of viruses. • Nanoparticles can be integrated into materials to confer sterilizing properties • Efficacy of nanoparticles to inactivate other viruses, such as influenza, HIV-1, and norovirus, can be used to extrapolate mechanisms that could also inhibit SARS-CoV-2 pathogenesis